Bristol-Myers Executive Accused Of Insider Trading

by The Compliance Exchange on August 2, 2012

Bristol-Myers Executive Accused Of Insider TradingBristol-Myers Squibb Co. (BMY) executive Robert Ramnarine was charged with insider trading for making $311,361 in illegal profit by buying stock options in three companies targeted for acquisition.

The FBI arrested Ramnarine, 45, this morning, and he will appear today in federal court in Newark, New Jersey, according to a statement by U.S. Attorney Paul Fishman. Ramnarine’s jobs included executive director of pensions and savings investments and assistant treasurer for capital markets.

Read Full Article At Bloomberg

Leave your comment


Required. Not published.

If you have one.

Web Design by Dashing Web Design